申请人:Translate Bio, Inc.
公开号:US10286083B2
公开(公告)日:2019-05-14
The present invention provides, in part, a biodegradable compound of formula I, and sub-formulas thereof: Formula (I) or a pharmaceutically acceptable salt thereof, where each X independently is O or S, each Y independently is O or S, and each R1 independently is defined herein; and a liposome composition comprising the cationic lipid of formula I or a sub-formula thereof, and methods of delivering agents, such as nucleic acids including mRNA, in vivo, by administering to a subject the liposome comprising the cationic lipid of formula I or a sub-formula thereof, where the agent is encapsulated within the liposome.
本发明部分提供了一种可生物降解的式 I 及其子式化合物:式(I)或其药学上可接受的盐,其中每个X独立地为O或S,每个Y独立地为O或S,每个R1独立地在本文中定义;以及包含式I阳离子脂质或其亚式的脂质体组合物,以及通过向受试者施用包含式I阳离子脂质或其亚式的脂质体的脂质体在体内递送药剂(如核酸,包括mRNA)的方法,其中药剂被包裹在脂质体内。